Crossmark

Evidence mounts for anti-CGRP treatment in cluster headache

Crossref DOI link: https://doi.org/10.1038/s41582-018-0063-2

Published Online: 2018-08-24

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leone, Massimo https://orcid.org/0000-0001-7475-4049
License Information

Text and Data Mining valid from 2018-08-24
More Information

Article History

First Online: 24 August 2018

Competing interests

: The author has received fees from Eli Lilly and TEVA for serving on their advisory boards.